================================================================================
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
---------------------
FORM 8-K
Current Report Filed Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report
(Date of earliest event reported): February 7, 2000
ENERGY BIOSYSTEMS CORPORATION
(Exact name of registrant as specified in its charter)
Delaware 0-21130 04-3078857
(State or other jurisdiction of (Commission File Number) (I.R.S. Employer Identification No.)
incorporation or organization)
4200 Research Forest Drive
The Woodlands, Texas 77381
(Address of principal
executive offices
and zip code)
(281) 364-6100
(Registrant's telephone number,
including area code)
================================================================================
ITEM 5. OTHER EVENTS
On February 7, 2000, Energy BioSystems Corporation (the "Company")
issued a press release announcing that it has completed the demonstration of a
new, proprietary gene shuffling technology. Gene shuffling is a method to create
a new, proprietary genes coding for enzymes with improved properties. The
Company has successfully applied the technology to its biodesulfurization
development efforts and is now exploring opportunities for the technology in
areas beyond biorefining including the chemical, pharmaceutical and agricultural
biotechnology sectors.
The press release is filed as an exhibit to this Current Report on Form
8-K and is incorporated by reference herein.
ITEM 7. EXHIBITS
Exhibit 99.1 -- Press Release
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
ENERGY BIOSYSTEMS CORPORATION
Date: February 7, 2000
By: /s/ Paul G. Brown, III
------------------------
Paul G. Brown, III
Vice President, Finance and
Administration and Chief
Financial Officer